SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Sir John Franklin — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientSir John Franklin
Date of birth1786-04-16
IdentifiersMRN HR-EX005-SYN-TD; SSN (made up) 000-05-3328
Document date1845-05-05
AuthorCordelia Ashby-Nwankwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Pre-departure review two weeks before sailing. [S]

History of Present Illness

Sir John sails in two weeks. His home readings this week average 126/78 on amlodipine 5 mg, with no side effects. He has lost 3.9 kg since intake by his own plan and counts his weight goal as met. He is sleeping well and is busy and cheerful; he knows the polar winters will be long and dark and has planned a routine of work, lessons and exercise for the officers and men. He has his clothing, a home blood pressure monitor with a spare cuff, and copies of his medical plan for the ship's surgeons. He has had every planned vaccine except the second zoster dose, due today. [S]

ElementDetail
Home readingsSeven-day average 126/78 mmHg
Weight86.9 kg, from 90.8 at intake
MoodPHQ-9 2, item 9 scored 0; GAD-7 3
Vitamin D34 ng/mL on vitamin D3
Kidney functionCreatinine 0.96 mg/dL, eGFR 90; potassium 4.3

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy good; sleeping seven hours
CardiovascularNegativeNo chest pain, palpitations or ankle swelling
Ears, nose, mouth, and throatPositiveTrouble hearing in noisy rooms, unchanged
PsychiatricNegativeMood good; no worry he cannot manage

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 5 mg oral tablet once dailyOne tablet by mouth every morningOral route1845-01-27activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar wintersOne tablet by mouth dailyOral route1845-01-27activeS
Vitamin C (ascorbic acid) 250 mg oral tablet once daily for the whole expedition, stored sealed and away from heat and light, in addition to food sourcesOne tablet by mouth daily from departureOral route1845-05-05activeS
Oseltamivir 75 mg oral capsule twice daily for five daysOne capsule by mouth twice a day for five daysOral route1845-02-10 to 1845-02-14completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1845-05-05Body height170cmS
1845-05-05Body weight86.9kgS
1845-05-05Body mass index (BMI) [Ratio]30.1kg/m2S
1845-05-05Systolic blood pressure126mm[Hg]S
1845-05-05Diastolic blood pressure76mm[Hg]S
1845-05-05Heart rate68/minS
1845-05-05Respiratory rate14/minS
1845-05-05Body temperature36.6CelS
1845-05-05Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1845-05-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-146 mmol/LNormalS
1845-05-05Potassium [Moles/volume] in Serum or Plasma4.3mmol/L3.5-5.3 mmol/LNormalS
1845-05-05Creatinine [Mass/volume] in Serum or Plasma0.96mg/dL0.7-1.3 mg/dLNormalS
1845-05-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M90mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1845-05-0525-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mLBelow 20 ng/mL deficient; 20 to 29 insufficientNormalS
1845-05-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
1845-05-05Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S

Physical Exam

Vital signs recorded on 1845-05-05; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 126/76, pulse 68; weight 86.9 kg, BMI 30.1; waist 101 cm
CardiovascularRegular rhythm; no murmur; no edema
SkinHands, feet and face intact; no old cold injury

Problems

ProblemClinical statusVerificationCodeProvenance
High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirmresolvedconfirmed R03.0S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension.
Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; syntheticactiveconfirmed I10S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded.
Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and foodactiveconfirmed E66.811S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded.
Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation planactiveconfirmed Z71.84S — Synthetic travel-health problem anchored to the documented expedition.
Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy roomsactiveconfirmed H83.3X3S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic.
Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness aheadactiveconfirmed E55.9S — Synthetic laboratory finding at intake.
Influenza A, confirmed by rapid molecular test, with fever, cough and aches, without pneumonia; treated with oseltamivir; recovered with a lingering coughresolvedconfirmed J10.1S — Synthetic modern illness anchored to the documented severe influenza of the winter before the expedition; the test, course and treatment are synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure (seated, five minutes' rest, large cuff, average of two readings)Every visitCompleted today126/76 mmHg
Self-managementHome blood pressure monitoringAt diagnosis and two to four weeks after each treatment change, then weeklyCompleted todayAverage 126/78 mmHg; weekly readings on board
ExaminationWeight, BMI and waistEvery visitCompleted today86.9 kg, BMI 30.1, waist 101 cm; 4.3 percent lost
ExaminationCardiac auscultationEvery visitCompleted todayNo murmur or gallop
LaboratoryBasic metabolic panel, potassium and eGFRYearly (every six months only on a diuretic or renin-angiotensin blocker)Completed todaySodium 139, potassium 4.3, creatinine 0.96 mg/dL, eGFR 90: a baseline before departure
Laboratory25-hydroxyvitamin DThree months after starting vitamin D3Completed today34 ng/mL, from 22
LaboratoryLipid panel and HbA1c or fasting glucoseYearlyUp to dateDue on his return
SurveyPHQ-9 depression screen and GAD-7Yearly, and before isolationCompleted todayPHQ-9 2 with item 9 scored 0; GAD-7 3
Medication safetyAmlodipine safety: ankle swelling, dizziness, flushingAt each visitCompleted todayNo side effects; three-year supply dispensed with written dose rules
Self-managementNutrition and food safety for the expedition (vitamin C and D, rations, cans, lead, botulism)Before departureCompleted todayVitamin C 250 mg daily from today; vitamin D3 continued; can inspection rules in writing
Self-managementCold injury and hypothermia preventionBefore departureUp to dateTraining done; clothing fitted
Self-managementMedical kit, written plan for the ship's surgeons, and evacuation planBefore departureCompleted todayKit list, written plan for the surgeons, and his written wishes for serious illness on board

Goal progress:

Immunizations given today: Recombinant zoster vaccine, second of two doses [S]

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension and hyperlipidemia monographs (2026); Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Frostbite: 2024 Update (2024); Wilderness Medical Society Clinical Practice Guidelines for the Out-of-Hospital Evaluation and Treatment of Accidental Hypothermia: 2019 Update (2019); Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021 (2021); Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions (2018); Depression and Suicide Risk in Adults: Screening (2023)

Follow-up: Full review on his return, with lipids, HbA1c, kidney function, urine albumin and blood lead. [S]